Semaglutides ability to promote significant weight loss can help alleviate the strain that excess weight places on the heart and blood vessels
Results appear gradually over 412 weeks, with a series of treatments recommended for optimal sculpting and definition
The report adds that consumers are making "meaningful changes in consumption behavior," with more than 50% of users reducing calorie intake by 20% or more
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
Moderate nausea means it slowed you down or made you skip a meal